CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash Flows from Operating Activities
Net Loss	$ (1,933,003)	$ (6,501,621)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation and amortization	1,134	1,091
Stock option expense	0	642,492
Stock issued for services	0	48,000
Financing fee	0	20,600
Change in fair value of convertible bridge loans	2,448	817
Loss on extinguishment of debt	20,298	4,259,987
Loss from Ebenberg JV	0	96,131
Amortization of debt discount	2,569	461,842
Amortization of right of use asset	37,463	33,609
Changes in operating assets and liabilities:
Prepaids	(3,155)	(1,444)
Accounts payable and accrued liabilities	866,168	(72,429)
Accrued liability, related party	(12,500)	10,000
Lease liabilities	(41,316)	(36,111)
Net cash from operating activities	(1,059,894)	(1,037,036)
Cash Flows from Investing Activities
Cash issued for notes receivable	(139,947)	0
Cash repayments for notes receivable	131,784	0
Investment in JV Movychem	0	(192,262)
Purchase of property and equipment	0	(2,567)
Net cash from financing activities	(8,163)	(194,829)
Cash Flows from Financing Activities
Proceeds from convertible bridge loans	1,380,000	270,000
Net cash from financing activities	1,380,000	270,000
Net change in cash	311,943	(961,865)
Cash at beginning of period	61,625	1,065,945
Cash at end of period	373,568	104,080
Supplemental Cash Flow Information
Cash paid for interest	0	0
Cash paid for income taxes	0	0
Non-cash investing and financing activities:
Conversion of convertible notes payable and accrued interest	321,115	0
Warrants issued with convertible notes payable extinguishment	0	80,114
Warrants issued with convertible notes payable	$ 66,660	$ 0